Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism

Roethle, 2013, Identification and optimization of pteridinone Toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis, J Med Chem, 56, 7324, 10.1021/jm400815m Akira, 2004, Toll-like receptor signalling, Nat Rev Immunol, 4, 499, 10.1038/nri1391 Birmachu, 2007, Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists, BMC Immunol, 8, 26, 10.1186/1471-2172-8-26 Hanten, 2008, Comparison of human B cell activation by TLR7 and TLR9 agonists, BMC Immunol, 9, 39, 10.1186/1471-2172-9-39 Oh, 2011, TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway, Blood, 118, 3028, 10.1182/blood-2011-04-348839 Lanford, 2013, GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees, Gastroenterology, 144, 1508, 10.1053/j.gastro.2013.02.003 Menne, 2015, Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the woodchuck model of chronic hepatitis B, J Hepatol, 62, 1237, 10.1016/j.jhep.2014.12.026 Isorce, 2016, Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus, Antiviral Res, 130, 36, 10.1016/j.antiviral.2016.03.008 Lutgehetmann, 2011, Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice, Gastroenterology, 140, 2074, 10.1053/j.gastro.2011.02.057 Niu, 2017, The Smc5/6 complex restricts HBV when localized to ND10 without inducing an innate immune response and is counteracted by the HBV X protein shortly after infection, PLoS One, 12, e0169648, 10.1371/journal.pone.0169648 Schoggins, 2011, A diverse range of gene products are effectors of the type I interferon antiviral response, Nature, 472, 481, 10.1038/nature09907 Li, 2012, MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen, Hepatology, 56, 803, 10.1002/hep.25608 Yan, 2015, Interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion, J Virol, 89, 9200, 10.1128/JVI.00933-15 Lucifora, 2014, Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA, Science, 343, 1221, 10.1126/science.1243462 Xia, 2016, Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis, Gastroenterology, 150, 194, 10.1053/j.gastro.2015.09.026 Decorsière, 2016, Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor, Nature, 531, 386, 10.1038/nature17170 Gehring, 2007, The level of viral antigen presented by hepatocytes influences CD8 T-cell function, J Virol, 81, 2940, 10.1128/JVI.02415-06 Robek, 2007, Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus, J Virol, 81, 483, 10.1128/JVI.01779-06 Sastry, 2011, Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody, J Virol, 85, 1935, 10.1128/JVI.01990-10 Allweiss, 2014, Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration, J Hepatol, 60, 500, 10.1016/j.jhep.2013.10.021 Isogawa, 2005, Toll-like receptor signaling inhibits hepatitis B virus replication in vivo, J Virol, 79, 7269, 10.1128/JVI.79.11.7269-7272.2005 Li, 2018, Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells, J Hepatol, 68, 912, 10.1016/j.jhep.2017.12.008 Belloni, 2012, IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome, J Clin Invest, 122, 529, 10.1172/JCI58847 Tropberger, 2015, Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation, Proc Natl Acad Sci U S A, 112, E5715, 10.1073/pnas.1518090112 Riviere, 2015, HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase, J Hepatol, 63, 1093, 10.1016/j.jhep.2015.06.023 Wieland, 2004, Genomic analysis of the host response to hepatitis B virus infection, Proc Natl Acad Sci U S A, 101, 6669, 10.1073/pnas.0401771101 Fisicaro, 2012, Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV, Gastroenterology, 143, 1576, 10.1053/j.gastro.2012.08.041 Cheng, 2017, Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection, Hepatology, 10.1002/hep.29348 Thomsen, 2016, Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection, Hepatology, 64, 746, 10.1002/hep.28685 Fletcher, 2013, Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B, Hepatology, 57, 13, 10.1002/hep.25954 Dunn, 2009, Temporal analysis of early immune responses in patients with acute hepatitis B virus infection, Gastroenterology, 137, 1289, 10.1053/j.gastro.2009.06.054 Luangsay, 2015, Early inhibition of hepatocyte innate responses by hepatitis B virus, J Hepatol, 63, 1314, 10.1016/j.jhep.2015.07.014